Singapore

International Finance Corp has made its first appearance in the Singapore dollar market in seven years. Its new treasury hub allows the supranational to give greater attention to Asian markets, the borrower’s Flora Chao told GlobalCapital Asia.

Goldman Sachs’ chairman for Asia Pacific and vice-chairman of the firm, Mark Schwartz, has decided to retire at the end of 2016, bringing an end to his 27-year tenure at the bank.

Julius Baer made a successful comeback to the Singapore dollar market on October 13, shrugging off concerns around the downgrade of its existing subordinated notes to raise S$325m ($235m) from an additional tier one.

MMI International has picked four banks to arrange its new 144A/Reg S deal, and is set to meet investors from next week.

Syndication is under way for a A$500m ($380m) five year facility to support Philippine consumer food and beverage company Universal Robina Corp’s acquisition of Snack Brands Australia.

Keppel DC Reit Management has kicked open a rights issue worth up to S$279.5m ($201.4m), while Zhuguang Holdings Group Co has launched a HK$1.4bn ($180.4m) offering — both to fund acquisitions.

Fullerton Healthcare Corp is working with the Singapore regulator to resolve issues around its S$213.3m ($154.7m) IPO, with the delay causing some investors to consider pulling their bids.

Goldman Sachs has named Raghav Maliah as head of southeast Asia investment banking, while picking Dan Swift to lead the lender’s Singapore team.

Swiss private bank Julius Baer returned to the Singapore dollar market for an additional tier one, clinching a S$325m ($235m) deal at a lower coupon than its debut one year ago. The positive outcome came despite the noise around European banks and concerns over Moody’s downgrade of the issuer’s existing subordinated notes.

A diverse group of issuers forged ahead with their respective fundraisings on Thursday, seeking everything from dollars to Singapore dollars and green debt.

Singapore-listed Frasers Hospitality Real Estate Investment Trust has raised S$266m ($192.6m) from an oversubscribed rights issue.

Fullerton Healthcare Corp has wrapped up its Singapore listing at the bottom of guidance, valuing the deal at S$213.3m ($154.7m).